Tony Nominee Dorian Harewood receives BFA from CCM
Harewood attended CCM from 1969-72, but left before graduating to pursue his first acting job
Tony nominee Dorian Harewood was honored with a BFA in Musical Theatre from the University of Cincinnati College-Conservatory of Music on August 8. Harewood studied at CCM, but left the university in 1972 prior to graduating to pursue his first acting offer.
Dorian Harewood and Jennifer Heisey.
UC Vice President for Alumni and Donor Experience and Chief Alumni Officer Jennifer Heisey presented Harewood with his BFA in Musical Theatre in a special celebration at Bond 45 in New York. The celebration also included Broadway stars and fellow CCM alumni like Kevin McCollum (BFA Musical Theatre, ’84; HonDoc, '05) and CCM Senior Director of Development and Alumni Relations Elaine Cox.
Harewood recently received a 2024 Tony Award nomination for his performance as Older Noah in The Notebook, which is produced by McCollum and Bradley Reynolds (BFA Musical Theatre, '84). Learn more about CCM's connections to the 2024 Tony Awards.
Learn more about Harewood's celebration and view photos via Playbill. The event was also featured by the US Times Mirror, Times Square Chronicles and Digital Journal.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
UC Board votes to fund design for YMCA renovation
October 28, 2025
At its October 28, 2025 meeting, the University of Cincinnati Board of Trustees approved $5 million in funding to complete all design and pre-construction services required to renovate the interior of a former YMCA building located at 270 Calhoun Street.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.